Oncocyte to Acquire Chronix Biomedical
The transaction includes proprietary IP and technology for blood-based immune therapy monitoring and for transplant rejection testing.
Category: Lung Cancer
Lung Cancer
Latest
Lung Cancer
LatestGuardant Health, Janssen to Develop Liquid Biopsy Companion Diagnostic
The collaborators are pursuing regulatory approval of the Guardant360 CDx as a companion diagnostic for amivantamab for the treatment of NSCLC.
Lung Cancer
LatestSorry, No Posts Found
Targeted Cancer Medicine Offers Hope for Neuroblastoma Treatment
Targeted cancer treatment using an ALK inhibitor in combination with a PIM1 inhibitor can increase the chances of survival of children with an unfavorable prognosis.
Read MoreT2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
T2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More
AI Modeling Drives Genomic Profiling Similarity Score
Caris Life Sciences’ Molecular Intelligence GPS score aids in the characterization of cancer of unknown primary and atypical cases, while also identifying appropriate treatment options.
Read More
Blood Specimen Collection Device
Innovative device enhances ease of use and reduces the costs and environmental impact of blood sample collection, processing, and shipping.
Read More
Trial Demonstrates Potential of Blood Test to Reduce Late Detection of Lung Cancer
The Early Detection for Cancer of the Lung Scotland trial is believed to be the world’s largest trial for the detection of lung cancer using biomarkers.
Read MoreVeracyte Introduces Percepta Genomic Sequencing Classifier
The new genomic test is Veracyte’s first commercial product since the company signed a strategic collaboration with Johnson & Johnson Innovation.
Read More
Economic Study Reveals Ways to Improve the Cost-Benefit of Multigene Panel Sequencing for Advanced Non-Small Cell Lung Cancer
Multigene panels would deliver greater value if patients with actionable genetic mutations consistently received guided treatments.
Read More
Liquid Biopsies Guide Improved Cancer Treatment
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read MoreSaga Raises $4.1 Million to Advance Ultrasensitive Liquid Biopsies
The funds will be used to accelerate commercialization of Saga’s portfolio of kits and services, continue development of new products, and perform prospective clinical studies.
Read More
Immunohistochemistry Test Detects ROS1 Protein in Cancer
The biomarker may provide a cost-effective and efficient means to identify elevated ROS1 protein expression in cancer.
Read More
Genetic Cancer Test Granted FDA Breakthrough Device Designation
The designation’s accelerated regulatory review is intended to expedite use of the diagnostic in pharmaceutical trials.
Read More
Decision Expands Guardant360 Coverage to Most Solid Tumor Types
The draft LCD applies to advanced cancer patients who are covered by Medicare for next-generation sequencing of tumor tissue, but have insufficient or unavailable tissue samples.
Read More
Mayo Clinic Announces Collaboration to Develop Diagnostic for Lung Cancer
The tests will use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases.
Read MoreMRM Proteomics and Biodesix Partner to Develop Precision Lung Cancer Diagnostic
The companies’ collaboration underscores the need for proteomic data to enable precision medicine strategies for lung cancer patients.
Read MoreFDA Grants Breakthrough Device Designation for Companion Diagnostic by ArcherDx
If approved, the test could be the first FDA-approved multigene sequencing-based in vitro diagnostic to accept both plasma and FFPE-based inputs.
Read More